Suchergebnisse - "Pace, F"

PubPharm (319)

101

Pretreatment Endoscopy - Pro & Contra: Endoscopy Is Needed before Treatment in All Patients with Gastroesophageal Reflux Disease

in: Endoscopy | 2006

von Pace, F. | Manes, G. | Conio, M. | +1

102

On rising reflux and other matters

enthalten in: Digestive and liver disease | 2006

von Pace, F. | Bianchi Porro, G.

103

enthalten in: Digestive and liver disease | 2006

von Pace, F.

104

Pretreatment Endoscopy - Pro & Contra: Endoscopy Is Needed before Treatment in All Patients with Gastroesophageal Reflux Disease

enthalten in: Endoscopy | 2006

von Pace, F. | Manes, G. | Conio, M. | +1

105

Drugs Acting on Serotonin Receptors for the Treatment of Functional GI Disorders

enthalten in: Digestive diseases | 2006

von Tonini, M. | Pace, F.

106

24-hour ambulatory intraluminal pH-impedance in patients with non erosive reflux disease (NERD)

enthalten in: Digestive and liver disease | 2006

von Zentilin, P. | Fanucchi, M. | Dulbecco, P. | +6

107

NERD in tertiary care: Management strategies and out come after a 5-year follow-up

enthalten in: Digestive and liver disease | 2006

von Pace, F. | Pallotta, S. | Porro, G.

108

IBS in tertiary care after a 4 years follow-up: Outcome and relevance of rectal perception testing

enthalten in: Digestive and liver disease | 2006

von Pace, F. | Molteni, P. | Pallotta, S. | +2

109

Gerd symptoms in obstructive sleep apnoea patients

enthalten in: Digestive and liver disease | 2006

von Pace, F. | Casini, V. | Pallotta, S. | +5

110

Rabeprazole is equivalent to omeprazole in the treatment of erosive gastro-oesophageal reflux disease. A randomised, double-blind, comparative study of rabeprazole and omeprazole 20 mg in acute treatment of reflux oesophagitis, followed by a maintenance open-label, low-dose therapy with rabeprazole

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2005

von Pace, F. | Annese, V. | Prada, A. | +5